Viewing StudyNCT00136396



Ignite Creation Date: 2024-05-05 @ 11:47 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00136396
Status: COMPLETED
Last Update Posted: 2013-06-12
First Post: 2005-08-26

Brief Title: Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host Disease
Sponsor:
Organization: Dana-Farber Cancer Institute